CCI
DPLO

Columbus Circle Investors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Columbus Circle Investors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-175,336
Closed -$3.63M – 309
2017
Q3 		$3.63M Buy
+175,336
New +$2.96M 0.06% 185
2016
Q1 		– Sell
-438,070
Closed -$15M – 324
2015
Q4 		$15M Buy
438,070
+145,898
+50% +$4.55M 0.12% 166
2015
Q3 		$8.39M Buy
+292,172
New +$12.5M 0.07% 204
2015
Q2 		– Sell
-42,412
Closed -$1.47M – 320
2015
Q1 		$1.47M Buy
+42,412
New +$1.15M 0.01% 256

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Columbus Circle Investors's DPLO Position: Q4 2017 in Review

Columbus Circle Investors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2017, closing a stake of 175,336 shares — an estimated $3.63M sold.

Columbus Circle Investors first reported a position in DPLO in Q1 2015 and held it in 4 quarters. The position peaked at $15M in Q4 2015. 200 funds tracked by Wall St. Rank hold DPLO as of Q4 2017.

  • Columbus Circle Investors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2017 after selling out during the quarter.
  • Columbus Circle Investors sold 175,336 DIPLOMAT PHARMACY, INC. shares in Q4 2017, an estimated $3.63M.
  • Columbus Circle Investors first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 4 quarters.
  • Columbus Circle Investors's DIPLOMAT PHARMACY, INC. position peaked at $15M in Q4 2015.
  • 200 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2017.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.